The US Preventive Services Task Force (USPSTF) recently released a recommendation on screening for autism spectrum disorder (ASD).1 In truth, this was a non-recommendation that stands in stark contrast to clinician groups, including the American Academy of Pediatrics, that recommend systematic screening for ASD at ages 18 and 24 months.2 Finding insufficient evidence that screening for ASD changes outcomes in 18- to 30-month-old children, the USPSTF landed in a gray zone of neither supporting nor opposing screening. Instead, they deferred decision making to families and clinicians.
Veenstra-VanderWeele J, McGuire K. Rigid, Inflexible Approach Results in No Recommendation for Autism Screening. JAMA Psychiatry. 2016;73(4):327–328. doi:10.1001/jamapsychiatry.2016.0143
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: